These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1975162)

  • 1. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A; Hedner J; Svedmyr N
    Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma.
    Leblanc P; Knight A; Kreisman H; Borkhoff CM; Johnston PR
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):324-8. PubMed ID: 8756801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A; Svedmyr N
    Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells.
    Lötvall J; Lunde H; Ullman A; Törnqvist H; Svedmyr N
    Allergy; 1992 Oct; 47(5):477-83. PubMed ID: 1362481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
    Gongora HC; Wisniewski AF; Tattersfield AE
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of salmeterol in childhood asthma.
    Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
    Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.